Genenta Science's Series B Round

Genenta Science raised a round of funding on September 13, 2017.

Genenta Science develops a gene transfer strategy into autologous hematopoietic stem cells (HSCs) to target interferon-α expression to tumor-infiltrating monocytes/macrophages. An HIV-derived and gen…

Articles about Genenta Science's Series B Round: